Dr Shaun Chuah wins prize at Glasgow Research & Innovation Conference
Published: 18 June 2026
Dr Shaun Chuah has won an abstract prize at the Glasgow Research and Innovation Conference: Better Care, Brighter Futures, recognising his presentation on ChatIBD, an innovative AI tool that supports healthcare professionals caring for IBD patients.

The School of Infection & Immunity's Dr Shaun Chuah has won an abstract prize at the Glasgow Research and Innovation Conference: Better Care, Brighter Futures, held at the Queen Elizabeth University Hospital on 3 June 2026.
The award, made in the GI, Hepatology and Rheumatology parallel session, recognised his presentation on ChatIBD, an artificial intelligence tool that supports healthcare professionals caring for people with inflammatory bowel disease.
Crohn's disease and ulcerative colitis are complex, lifelong conditions, and the clinicians who treat them often need to check detailed guidance on treatments, monitoring, safety, pregnancy, infections and drug dosing.
ChatIBD, developed by Dr Chuah with Dr Beatriz Gros (Reina Sofía University Hospital, Córdoba) and Dr Nikolas Plevris (Western General Hospital, Edinburgh), turns trusted clinical guidelines into quick, readable answers and lets clinicians check the source material behind each one.
The aim is not to replace clinical judgement but to make high-quality medical knowledge easier to access and more consistent at the point of care.
ChatIBD also has the potential to widen access to specialist knowledge globally, particularly where subspecialty expertise or English-language guidance is limited. It is now used by clinicians in more than 75 countries and across 28 languages.
Dr Chuah said: "I'm really pleased ChatIBD has been recognised. Clinicians today have access to more guidance than ever, but finding what they need quickly in a busy clinic is hard.
"For me the measure of success is whether it helps clinicians on the front line get to the right answer faster, and that is starting to happen.
"Many thanks to Dr Beatriz Gros and Dr Nikolas Plevris, who have been central to this project."
First published: 18 June 2026